4//SEC Filing
LEA LEIV 4
Accession 0000899243-17-028853
CIK 0001626971other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:08 PM ET
Size
6.8 KB
Accession
0000899243-17-028853
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-12-13+40,000→ 40,000 totalExercise: $10.60Exp: 2027-12-13→ Common Stock (40,000 underlying)
Holdings
- 149,206(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (3)
- [F1]A portion of these shares is subject to a right of repurchase held by the Issuer.
- [F2]These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.
- [F3]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 13, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0000939012
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:08 PM ET
- Size
- 6.8 KB